EDGAR Filing Documents for 0001193125-14-429616

Form 8-K - Current report:

SEC Accession No. 0001193125-14-429616

Filing Date

2014-12-01

Accepted

2014-12-01 17:25:07

Documents

Period of Report

2014-11-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d828330d8k.htm	8-K	23644
2	EX-10.1	d828330dex101.htm	EX-10.1	148344
3	EX-10.2	d828330dex102.htm	EX-10.2	78944
4	EX-10.3	d828330dex103.htm	EX-10.3	68670
5	EX-99.1	d828330dex991.htm	EX-99.1	9090
6	GRAPHIC	g828330eleven.jpg	GRAPHIC	20057
	Complete submission text file	0001193125-14-429616.txt		357699

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142

Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)